[1]马浩源 杨乔 宋怡瑶 徐国栋 董艳红 吕佩源.血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂替罗非班在急性缺血性脑卒中血管内治疗中的研究进展[J].卒中与神经疾病杂志,2020,27(01):133-135.[doi:10.3969/j.issn.1007-0478.2020.01.032]
点击复制

血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂替罗非班在急性缺血性脑卒中血管内治疗中的研究进展()
分享到:

《卒中与神经疾病》杂志[ISSN:1007-0478/CN:42-1402/R]

卷:
第27卷
期数:
2020年01期
页码:
133-135
栏目:
综 述
出版日期:
2020-01-30

文章信息/Info

文章编号:
1007-0478(2020)01-0133-03
作者:
马浩源 杨乔 宋怡瑶 徐国栋 董艳红 吕佩源
050000 石家庄,河北省人民医院神经内科[马浩源(华北理工大学研究生学院)杨乔(河北北方学院研究生学院)宋怡瑶(华北理工大学研究生学院)徐国栋 董艳红 吕佩源(通讯作者)]
分类号:
R543.4
DOI:
10.3969/j.issn.1007-0478.2020.01.032
文献标志码:
A

参考文献/References:

[1] Teng DY,Pannell JS,Rennert RC,et al.Endothelial trauma from mechanical thrombectomy in acute stroke in vitro Live-Cell platform with animal validation[J].Stroke,2015,46(4):1099-1106.
[2]Heo JH,Lee KY,Kim SH,et al.Immediate reocclusion following a successful thrombolysis in acute stroke: A pilot study[J].Neurology,2003,60(10):1684-1687.
[3]Casserly IP,Topol EJ.Glycoprotein Ⅱb/Ⅲa antagonists-from bench to practice[J].Cellular and Molecular Life Sciences,2002,59(3):478-500.
[4]Peerlinck K,De Lepeleire I,Goldberg M,et al.MK-383(L-700,462),a selective nonpeptide platelet glycoprotein Ⅱb/Ⅲa antagonist,is active in man[J].Circulation,1993,88(4 Pt 1):1512-1517.
[5]Shattil SJ,Newman PJ.Integrins: dynamic scaffolds for adhesion and signaling in platelets[J].Blood,2004,104(6):1606-1615.
[6]Murugappan S,Shankar H,Kunapuli SP.Platelet receptors for adenine nucleotides and thromboxane A2[J].Semin Thromb Hemost,2004,30(4):411-418.
[7]Schwarz M,Meade G,Stoll P,et al.Conformation-specific blockade of the integrin GPⅡb/Ⅲa-A novel antiplatelet strategy that selectively targets activated platelets[J].Circ Res,2006,99(1):25-33.
[8]Zhang Z,Li W,Wu W,et al.Myocardial reperfusion with tirofiban injection via aspiration catheter:Efficacy and safety in STEMI patients with large thrombus burden[J].Herz,2018,doi:10.1007/s00059-018-4716-0.
[9]Abumiya T,Fitridge R,Mazur C,et al.Integrin alpha(Ⅱb)beta(3)inhibitor preserves microvascular patency in experimental acute focal cerebral ischemia[J].Stroke,2000,31(6):1409-1410.
[10]Barrett JS,Murphy G,Peerlinck K,et al.Pharmacokinetics and pharmacodynamics of MK-383,a selective non-peptide platelet glycoprotein-Ⅱb/Ⅲa receptor antagonist,in healthy men[J].Clin Pharmacol Ther,1994,56(4):377-388.
[11]Power S,Matouk C,Casaubon LK,et al.Vessel wall magnetic resonance imaging in acute ischemic stroke effects of embolism and mechanical thrombectomy on the arterial wall[J].Stroke,2014,45(8):2330-2334.
[12]Li Y,Li Q,Li F,et al.Evaluation of short-and Long-Term efficacy of combined intracoronary administration of High-Dose adenosine and tirofiban during primary percutaneous coronary intervention[J].Acta Cardiologica Sinica,2016,32(6):640-648.
[13]Elcioglu OC,Ozkok A,Akpinar TS,et al.Severe thrombocytopenia and alveolar hemorrhage represent two types of bleeding tendency during tirofiban treatment: case report and literature review[J].Int J Hematol,2012,96(3):370-375.
[14]Janjua N,Alkawi A,Suri M,et al.Impact of arterial reocclusion and distal fragmentation during thrombolysis among patients with acute ischemic stroke[J].American Journal of Neuroradiology,2008,29(2):253-258.
[15]Kim GE,Yoon W,Kim SK,et al.Incidence and clinical significance of acute reocclusion after emergent angioplasty or stenting for underlying intracranial stenosis in patients with acute stroke[J].American Journal of Neuroradiology,2016,37(9):1690-1695.
[16]Ernst M,Butscheid F,Fiehler J,et al.Glycoprotein Ⅱb/Ⅲa inhibitor bridging and subsequent endovascular therapy in vertebrobasilar occlusion in 120 patients[J].Clin Neuroradiol,2016,26(2):169-175.
[17]Luo Y,Yang Y,Xie Y,et al.Therapeutic effect of pre-operative tirofiban on patients with acute ischemic stroke with mechanical thrombectomy within 6-24 hours[J].Interv Neuroradiol,2019,25(6):705-709.
[18]Feng L,Liu J,Liu YZ,et al.Tirofiban combined with urokinase selective intra-arterial thrombolysis for the treatment of middle cerebral artery occlusion[J].Exp Ther Med,2016,11(3):1011-1016.
[19]Kwon JH,Shin SH,Weon YC,et al.Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients[J].Neuroradiology,2011,53(10):779-785.
[20]Kang DH,Yoon W,Kim SK,et al.Endovascular treatment for emergent large vessel occlusion due to severe intracranial atherosclerotic stenosis[J].J Neurosurg,2019,130(6):1949-1956.
[21]Gruber P,Hlavica M,Berberat J,et al.Acute administration of tirofiban versus aspirin in emergent carotid artery stenting[J].Interventional Neuroradiology,2019,25(2):219-224.
[22]Zhao WB,Che RW,Shang SY,et al.Low-Dose tirofiban improves functional outcome in acute ischemic stroke patients treated with endovascular thrombectomy[J].Stroke,2017,48(12):3289-3294.
[23]Zhao HC,Zhang JH,Gu DY,et al.Tirofiban facilitates the reperfusion process during endovascular thrombectomy in ICAS[J].Exp Ther Med,2017,14(4):3314-3318.
[24]Kim JW,Jeon P,Kim GM,et al.Local intraarterial tirofiban after formation of anterograde flow in patients with acute ischemic stroke: Preliminary experience and short term follow-up results[J].Clin Neurol Neurosurg,2012,114(10):1316-1319.
[25]Yu TY,Lin YY,Jin AP,et al.Safety and efficiency of low dose intra-arterial tirofiban in mechanical thrombectomy during acute ischemic stroke[J].Curr Neurovasc Res,2018,15(2):145-150.
[26] Wu Y,Yin C,Yang J,et al.Endovascular thrombectomy[J].Stroke,2018,49(11):2783-2785.

备注/Memo

备注/Memo:
基金项目:2014年政府资助临床医学优秀人才培养项目(编号为361003)(2019-07-15 收稿)
更新日期/Last Update: 2020-01-30